Literature DB >> 23073486

Scleral contact lenses as an alternative to tarsorrhaphy for the long-term management of combined exposure and neurotrophic keratopathy.

Marlies Weyns1, Carina Koppen, Marie-José Tassignon.   

Abstract

PURPOSE: Most ophthalmologists are unaware of the therapeutic applications of gas-permeable scleral contact lenses for the prevention and treatment of ocular complications in patients with facial nerve palsy and concomitant neuroparalysis.
METHODS: The case reports refer to 3 patients who developed unilateral lagophthalmos and corneal anesthesia after an acoustic neuroma or intracranial tumor resection. Two patients explicitly requested a tarsorrhaphy to be opened because they were incapacitated by the limited visual acuity and visual field. Tarsorrhaphy was not an acceptable aesthetic solution for the third patient. Fluid-ventilated scleral lenses were fitted because they protect the cornea by creating a precorneal fluid reservoir while optimizing visual acuity.
RESULTS: The follow-up periods were 3, 17, and 18 years. Two patients wear the contact lenses full time, but the wearing time is limited to 10 hours per day for the third patient. All patients were instructed not to wear their lenses while sleeping. Two eyes required a corneal transplant, but lens wear could be resumed 4 to 6 weeks after transplantation. The learning curve for the insertion and removal of this large-diameter lens is the main obstacle for a patient, especially when there is loss of corneal sensation.
CONCLUSION: Scleral lens wear is a valid long-term alternative to standard treatment options such as tarsorrhaphy for patients with corneal exposure and corneal anesthesia as a consequence of postsurgery facial nerve paralysis. Scleral contact lenses provide these patients with effective protection of the ocular surface in an aesthetically acceptable way while optimizing visual function.

Entities:  

Mesh:

Year:  2013        PMID: 23073486     DOI: 10.1097/ICO.0b013e31825fed01

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

Review 1.  Neuro-ophthalmological approach to facial nerve palsy.

Authors:  Joana Portelinha; Maria Picoto Passarinho; João Marques Costa
Journal:  Saudi J Ophthalmol       Date:  2014-09-28

2.  Efficacy of treatments for neurotrophic keratopathy: a systematic review and meta-analysis.

Authors:  Sébastien Roumeau; Frédéric Dutheil; Vincent Sapin; Julien S Baker; Stephanie L Watson; Bruno Pereira; Frédéric Chiambaretta; Valentin Navel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-07       Impact factor: 3.535

3.  Evaluation of artificial tears on cornea epithelium healing.

Authors:  Ying Zhang; Xiao-You Lu; Ren-Jian Hu; Fang-Li Fan; Xiu-Ming Jin
Journal:  Int J Ophthalmol       Date:  2018-07-18       Impact factor: 1.779

Review 4.  [Rehabilitation of facial palsy and vertigo in patients with vestibular schwannoma].

Authors:  B Müller; G F Volk; O Guntinas-Lichius
Journal:  HNO       Date:  2017-09       Impact factor: 1.284

5.  A non-surgical approach to the management of exposure keratitis due to facial palsy by using mini-scleral lenses.

Authors:  Victor Zaki
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

Review 6.  Treatment of Non-Infectious Corneal Injury: Review of Diagnostic Agents, Therapeutic Medications, and Future Targets.

Authors:  Deanna H Dang; Kamran M Riaz; Dimitrios Karamichos
Journal:  Drugs       Date:  2022-01-13       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.